查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1718942

造影超音波市场评估:各产品，各用途，各终端用户，各地区，机会，预测，2018年～2032年

Contrast Enhanced Ultrasound Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 239 Pages | 商品交期: 3-5个工作天内

价格

全球造影超音波市场预计将从2024年的22.9亿美元成长到2032年的36.2亿美元，在2025-2032年的预测期内，复合年增长率为5.87%。市场成长的动力源于超音波检查需求的不断增长、价格实惠的造影剂供应的日益增加，以及人们对造影成像模式与超音波技术融合的日益关注。此外，人口老化也在推动市场成长。世界卫生组织 (WHO) 估计，到2030年，全球六分之一的人口将达到60岁或以上。

随着全球老年人口的增长，需要频繁且先进的影像诊断的与年龄相关的慢性疾病（例如心血管疾病、癌症和肝病）的数量预计也将增加。超音波造影尤其适用于老年患者，因为它是非侵入性的，不涉及电离辐射。此外，对于肾功能不全的患者来说，该技术比使用肾毒性造影剂的CT和MRI更安全。此外，全球越来越多的医疗保健专业人员正在使用造影超音波来管理和早期发现慢性疾病和病症。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 美国的关税的影响

第4章 摘要整理

第5章 全球造影超音波市场展望，2018年～2032年

  • 市场规模分析与预测
    • 各金额
    • 各数量
  • 市场占有率分析与预测
    • 各产品
      • 设备
      • 显影剂
      • 软体·服务
    • 各用途
      • 诊断用途
      • 治疗用途
    • 各终端用户
      • 医院·外科中心
      • 诊断影像中心
      • 门诊病人手术中心
      • 其他
    • 各地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东·非洲
    • 各企业市场占有率分析(前五名公司和其他-各金额，2024年)
  • 市场地图分析，2024年
    • 各产品
    • 各用途
    • 各终端用户
    • 各地区

第6章 北美的造影超音波市场展望，2018年～2032年

  • 市场规模分析与预测
    • 各金额
    • 各数量
  • 市场占有率分析与预测
    • 各产品
      • 设备
      • 显影剂
      • 软体·服务
    • 各用途
      • 诊断用途
      • 治疗用途
    • 各终端用户
      • 医院·外科中心
      • 诊断影像中心
      • 门诊病人手术中心
      • 其他
    • 各国占有率
      • 美国
      • 加拿大
      • 墨西哥
  • 各国市场评估
    • 美国的造影超音波市场展望，2018年～2032年*
      • 市场规模分析与预测
      • 市场占有率分析与预测
    • 加拿大
    • 墨西哥

所有细分市场均涵盖所有地区和国家。

第7章 欧洲的造影超音波市场展望，2018年～2032年

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 土耳其
  • 波兰

第8章 亚太地区的造影超音波市场展望，2018年～2032年

  • 印度
  • 中国
  • 日本
  • 澳洲
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第9章 南美的造影超音波市场展望，2018年～2032年

  • 巴西
  • 阿根廷

第10章 中东·非洲的造影超音波市场展望，2018年～2032年

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非

第11章 需求供给分析

第12章 进口和出口的分析

第13章 价值链分析

第14章 波特的五力分析

第15章 大环境分析

第16章 价格分析

第17章 市场动态

  • 推动市场要素
  • 市场课题

第18章 市场趋势与发展

第19章 法规情形和革新

第20章 专利的形势

第21章 案例研究

第22章 竞争情形

  • 前五名市场领导公司的竞争矩阵
  • 前五大企业的SWOT分析
  • 市场前十名的主要企业的形势
    • Lantheus Medical Imaging, Inc.
      • 公司概要
      • 主要经营团队
      • 产品和服务
      • 财务状况(报告那样)
      • 主要市场的着重和地理存在感
      • 最近的趋势/合作/伙伴关係/合併和收购
    • GE HealthCare Technologies Inc.
    • Bracco Imaging SPA
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Canon Inc.
    • Esaote SPA
    • Samsung Electronics Co., Ltd
    • Guerbet SA

以上公司并非依市占率排序，且可能会根据研究工作中可用的资讯而有所变动。

第23章 策略性建议

第24章 关于调查公司·免责声明

Product Code: MX13067

Global contrast enhanced ultrasound market is projected to witness a CAGR of 5.87% during the forecast period 2025-2032, growing from USD 2.29 billion in 2024 to USD 3.62 billion in 2032. The market's growth is bolstered by the increasing requirement for ultrasound procedures, rising accessibility of affordable contrast agents, and growing focus on integrating contrast imaging modes with ultrasound technologies. Additionally, the expansion of the aging population is also driving the market's growth. The World Health Organization estimates that 1 in 6 people across the world will be 60 or older by 2030.

As the global geriatric population increases, the number of age-related chronic diseases such as cardiovascular disorders, cancers, and liver diseases, all of which require frequent and advanced diagnostic imaging, is also expected to rise. Contrast-enhanced ultrasound is particularly well-suited for elderly patients due to its non-invasive nature and lack of involvement in ionizing radiation. Additionally, the technology is safer for those with renal impairment compared to CT or MRI, which use nephrotoxic contrast agents. Healthcare professionals across the globe are also increasingly utilizing contrast-enhanced ultrasound for the management of chronic diseases and disorders and ensuring their early detection.

Increasing Prevalence of Kidney Diseases Boosts Market Demand

The rising prevalence of kidney diseases in various regions across the globe is one of the major drivers of the market. According to estimates from the National Institute of Diabetes and Digestive and Kidney Diseases, chronic kidney disease affects over 1 in 7 adults in the United States. This growth is augmenting the requirement for contrast-enhanced ultrasound due to its relatively safe, non-invasive, and effective nature. Additionally, it provides cost-effective, real-time, high-resolution imaging, enabling frequent monitoring and ensuring early detection of kidney diseases and their progression or complications. Moreover, technology is also valuable for patients who cannot undergo repeated biopsies and invasive procedures, providing a reliable alternative for longitudinal disease assessment.

Rising Initiatives to Boost Awareness About Contrast Enhanced Ultrasound

Increasing initiatives to boost awareness about contrast-enhanced ultrasound across the globe are significantly driving the growth of the market by promoting its clinical benefits, safety profile, and expanding applications. Internationally recognized organizations, such as the American Institute of Ultrasound in Medicine and the International Contrast Ultrasound Society, are focusing on launching educational campaigns, developing clinical guidelines, and engaging with regulatory bodies to address misconceptions and regulatory barriers while boosting awareness about the various advantages associated with the technology, thereby increasing acceptance among patients and clinicians.

For instance, in April 2024, the Northwest Imaging Forums and the International Contrast Ultrasound Society announced an educational partnership to train sonographers to administer intravenous contrast agents and perform contrast-enhanced ultrasound examinations. As more patients and medical professionals become informed about the diagnostic accuracy, safety, and cost-effectiveness associated with contrast-enhanced ultrasound, the demand for these systems and contrast agents is expected to increase. Such initiatives are also expanding the role of contrast-enhanced ultrasounds in modern diagnostics, driving the growth of the market by ensuring broader clinical utilization and acceptance of technology.

Hospitals and Surgical Centers Account for Significant Share of the Market

Hospitals and surgical centers account for a significant share of the contrast-enhanced ultrasound market as these facilities are equipped with skilled personnel and advanced imaging solutions, which are essential for detailed visualization and real-time analysis of tissue perfusion, blood flow, and organ functioning for accurate diagnosis and surgical planning. Hospitals receive a large number of patients suffering from chronic diseases, including cardiovascular disorders, liver diseases, and cancers, that directly benefit from the diagnostic precision provided by contrast-enhanced ultrasound.

The contrast-enhanced ultrasound is also increasingly being used in surgical centers, including ambulatory surgical centers, for intraoperative guidance and minimally invasive procedures, thus bolstering their adoption. Moreover, hospitals and surgical centers often act as referral centers for complex cases and ensure the availability of advanced imaging technologies such as contrast-enhanced ultrasound, further accelerating the growth of the market.

Additionally, increasing investments in upgrading hospitals across the globe are bolstering the demand for advanced technologies such as contrast-enhanced ultrasounds. For instance, the University of Pittsburgh Medical Center (UPMC) is investing USD 1.5 billion towards renovating and expanding its centerpiece Presbyterian Hospital tower, which will focus on cardiology, neurology, and transplants upon its completion. The hospital tower is expected to be completed in 2027.

North America Holds Major Share of the Market

The growth of the market in the region can be attributed to the strong presence of advanced healthcare infrastructure and medical device manufacturers, the availability of favorable reimbursement policies, and the rising requirements for point-of-care diagnostics. Moreover, the rise in the number of cases of chronic health conditions, including cancer, in countries such as Canada and the United States is also augmenting the demand for effective diagnostic tools such as contrast-enhanced ultrasound devices. As per the estimates of the Canadian Cancer Society, approximately 247,100 Canadians were expected to be diagnosed with cancer in 2024. Rising regulatory approvals for new contrast agents and extensive training and educational programs have also facilitated widespread clinical adoption across the region. Meanwhile, favorable reimbursement policies and rising investments in advanced medical technologies make it easier for healthcare professionals to integrate contrast-enhanced ultrasound into routine practice, further supporting the market's expansion.

Impact of the U.S. Tariff on Global Contrast Enhanced Ultrasound Market

The trade tensions occurring due to the imposed tariffs can indirectly affect the contrast-enhanced ultrasound market. Johnson & Johnson Services, Inc. estimates approximately USD 400 million in costs from tariffs that are already in place against aluminum and steel as well as China. The company also expects disruptions in the supply chain, resulting in a shortage of different medical technologies. To mitigate such challenges, the leading players in the market can focus on investing in strengthening their local manufacturing capabilities and diversifying their supply chains and enhancing resilience against trade-related disruptions.

Key Players Landscape and Outlook

The key players in the market are focusing on launching new products and technologies to ensure their expansion and provide advanced care for the patient population. For instance, in March 2023, Esaote S.P.A launched the MyLab X90 premium ultrasound system, which integrates augmented insights, including artificial intelligence (AI)-powered solutions with a multidisciplinary clinical approach. The system simplifies complex processes and makes advanced technologies more accessible in daily clinical practice while ensuring high-contrast resolution and clear imaging. Such launches aid in improving patient outcomes while allowing the key players in the market to strengthen their position in the market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Equipment
      • 5.2.1.2. Contrast Agents
        • 5.2.1.2.1. Molecule-Targeted Microbubbles
        • 5.2.1.2.2. Nanoparticle Microbubbles
      • 5.2.1.3. Software and Services
    • 5.2.2. By Application
      • 5.2.2.1. Diagnostic Applications
        • 5.2.2.1.1. Nephrology
        • 5.2.2.1.2. Cardiology
        • 5.2.2.1.3. Others
      • 5.2.2.2. Therapeutic Applications
        • 5.2.2.2.1. Cardiology
        • 5.2.2.2.2. Oncology
        • 5.2.2.2.3. Vascular
        • 5.2.2.2.4. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals and Surgical Centers
      • 5.2.3.2. Diagnostic Imaging Centers
      • 5.2.3.3. Ambulatory Surgery Center
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
    • 6.1.2. By Volume
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Product
      • 6.2.1.1. Equipment
      • 6.2.1.2. Contrast Agents
        • 6.2.1.2.1. Molecule-Targeted Microbubbles
        • 6.2.1.2.2. Nanoparticle Microbubbles
      • 6.2.1.3. Software and Services
    • 6.2.2. By Application
      • 6.2.2.1. Diagnostic Applications
        • 6.2.2.1.1. Nephrology
        • 6.2.2.1.2. Cardiology
        • 6.2.2.1.3. Others
      • 6.2.2.2. Therapeutic Applications
        • 6.2.2.2.1. Cardiology
        • 6.2.2.2.2. Oncology
        • 6.2.2.2.3. Vascular
        • 6.2.2.2.4. Others
    • 6.2.3. By End-user
      • 6.2.3.1. Hospitals and Surgical Centers
      • 6.2.3.2. Diagnostic Imaging Centers
      • 6.2.3.3. Ambulatory Surgery Center
      • 6.2.3.4. Others
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Contrast Enhanced Ultrasound Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
        • 6.3.1.1.2. By Volume
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Product
          • 6.3.1.2.1.1. Equipment
          • 6.3.1.2.1.2. Contrast Agents
          • 6.3.1.2.1.2.1. Molecule-Targeted Microbubbles
          • 6.3.1.2.1.2.2. Nanoparticle Microbubbles
          • 6.3.1.2.1.3. Software and Services
        • 6.3.1.2.2. By Application
          • 6.3.1.2.2.1. Diagnostic Applications
          • 6.3.1.2.2.1.1. Nephrology
          • 6.3.1.2.2.1.2. Cardiology
          • 6.3.1.2.2.1.3. Others
          • 6.3.1.2.2.2. Therapeutic Applications
          • 6.3.1.2.2.2.1. Cardiology
          • 6.3.1.2.2.2.2. Oncology
          • 6.3.1.2.2.2.3. Vascular
          • 6.3.1.2.2.2.4. Others
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Hospitals and Surgical Centers
          • 6.3.1.2.3.2. Diagnostic Imaging Centers
          • 6.3.1.2.3.3. Ambulatory Surgery Center
          • 6.3.1.2.3.4. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Contrast Enhanced Ultrasound Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Landscape and Innovation

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

  • 22.1. Competition Matrix of Top 5 Market Leaders
  • 22.2. SWOT Analysis for Top 5 Players
  • 22.3. Key Players Landscape for Top 10 Market Players
    • 22.3.1. Lantheus Medical Imaging, Inc.
      • 22.3.1.1. Company Details
      • 22.3.1.2. Key Management Personnel
      • 22.3.1.3. Products and Services
      • 22.3.1.4. Financials (As Reported)
      • 22.3.1.5. Key Market Focus and Geographical Presence
      • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 22.3.2. GE HealthCare Technologies Inc.
    • 22.3.3. Bracco Imaging S.P.A.
    • 22.3.4. Koninklijke Philips N.V.
    • 22.3.5. Siemens Healthineers AG
    • 22.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 22.3.7. Canon Inc.
    • 22.3.8. Esaote S.P.A
    • 22.3.9. Samsung Electronics Co., Ltd
    • 22.3.10. Guerbet SA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 2. Global Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 3. Global Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 4. Global Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Contrast Enhanced Ultrasound Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 8. North America Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 9. North America Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 10. North America Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Contrast Enhanced Ultrasound Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 14. United States Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 15. United States Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 16. United States Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 19. Canada Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 20. Canada Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 21. Canada Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 24. Mexico Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 25. Mexico Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 26. Mexico Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 29. Europe Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 30. Europe Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 31. Europe Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Contrast Enhanced Ultrasound Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 35. Germany Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 36. Germany Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 37. Germany Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 40. France Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 41. France Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 42. France Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 43. France Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 45. Italy Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 46. Italy Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 47. Italy Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 50. United Kingdom Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 51. United Kingdom Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 52. United Kingdom Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 55. Russia Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 56. Russia Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 57. Russia Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 60. Netherlands Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 61. Netherlands Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 62. Netherlands Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 65. Spain Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 66. Spain Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 67. Spain Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 70. Turkey Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 71. Turkey Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 72. Turkey Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 75. Poland Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 76. Poland Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 77. Poland Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 80. South America Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 81. South America Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 82. South America Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Contrast Enhanced Ultrasound Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 86. Brazil Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 87. Brazil Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 88. Brazil Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 91. Argentina Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 92. Argentina Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 93. Argentina Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 97. Asia-Pacific Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 98. Asia-Pacific Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Contrast Enhanced Ultrasound Market Share (%), By Country, 2018-2032F
  • Figure 101. India Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 102. India Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 103. India Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 104. India Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 105. India Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 107. China Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 108. China Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 109. China Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 110. China Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 112. Japan Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 113. Japan Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 114. Japan Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 117. Australia Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 118. Australia Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 119. Australia Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 122. Vietnam Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 123. Vietnam Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 124. Vietnam Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 127. South Korea Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 128. South Korea Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 129. South Korea Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 132. Indonesia Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 133. Indonesia Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 134. Indonesia Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 137. Philippines Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 138. Philippines Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 139. Philippines Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 143. Middle East & Africa Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 144. Middle East & Africa Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Contrast Enhanced Ultrasound Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 149. Saudi Arabia Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 150. Saudi Arabia Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 153. UAE Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 154. UAE Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 155. UAE Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Contrast Enhanced Ultrasound Market, By Value, in USD Billion, 2018-2032F
  • Figure 158. South Africa Contrast Enhanced Ultrasound Market, By Volume, in Million Units, 2018-2032F
  • Figure 159. South Africa Contrast Enhanced Ultrasound Market Share (%), By Product, 2018-2032F
  • Figure 160. South Africa Contrast Enhanced Ultrasound Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Contrast Enhanced Ultrasound Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024